NCT05034926View on ClinicalTrials.gov

A Study of Nivolumab in Participants With Locally Advanced or Metastatic (Stage IIIB-IV) Non-Small Cell Lung Cancer (NSCLC) With Squamous and Non-Squamous Histology After Prior Chemotherapy Treated in Real World Settings in Greece and Cyprus

UnknownOBSERVATIONAL
Enrollment

350

Participants

Timeline

Start Date

October 7, 2020

Primary Completion Date

September 15, 2025

Study Completion Date

September 15, 2025

Conditions
Non-Small Cell Lung Cancer
Trial Locations (1)

15561

Local Institution - 0001, Athens

Sponsors
All Listed Sponsors
lead

Bristol-Myers Squibb

INDUSTRY

NCT05034926 - A Study of Nivolumab in Participants With Locally Advanced or Metastatic (Stage IIIB-IV) Non-Small Cell Lung Cancer (NSCLC) With Squamous and Non-Squamous Histology After Prior Chemotherapy Treated in Real World Settings in Greece and Cyprus | Biotech Hunter | Biotech Hunter